United States Biotechnology & Medical Research

Aptevo Therapeutics Inc (APVO)

Track

The most recent insider trading activity at Aptevo Therapeutics Inc. occurred on November 10, 2025, when Grant Grady III executed a purchase of 13,513 shares valued at approximately $20,134. Prior to this, significant selling activity was recorded in November 2021 by Kevin C. Tang. No further insider transactions have been reported in the last three months.
Ticker: APVO Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Aptevo Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 10 Nov 2025
Value US$3,202,063.07 | Price 13.59 | Shares 5,350 (-4.4%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-12 2025-11-10 B Purchase
1.4
Grant Grady III
Non-Executive Director
5,350 -4.4%
13.59
US$3,202,063 		5,350 -4.4% 13.59 US$3,202,063
2021-11-26 2021-11-23 S Sale
3.3
TANG KEVIN C

Exit Filing
19,128 +30.8%
457.80
US$2,258,123 		19,128 +30.8% 457.80 US$2,258,123
2021-11-26 2021-11-23 S Sale
3.3
TANG KEVIN C

Exit Filing
28,080 -13.0%
66.73
US$1,276,793 		28,080 -13.0% 66.73 US$1,276,793
2021-11-26 2021-11-23 S Sale
3.3
TANG KEVIN C

Exit Filing
50,889 -12.4%
10.43
US$530,665 		50,889 -12.4% 10.43 US$530,665
2021-11-26 2021-11-23 S Sale
3.3
TANG KEVIN C

Exit Filing
149,111 -26.6%
11.19
US$1,668,433 		149,111 -26.6% 11.19 US$1,668,433
2021-11-26 2021-11-23 S Sale
3.3
TANG KEVIN C

Exit Filing
75,491 -11.9%
11.74
US$886,430 		75,491 -11.9% 11.74 US$886,430
2021-11-26 2021-11-23 S Sale
3.3
TANG KEVIN C

Exit Filing
124,509 -16.4%
12.45
US$1,550,187 		124,509 -16.4% 12.45 US$1,550,187
2021-11-26 2021-11-23 S Sale
3.3
TANG KEVIN C

Exit Filing
161,336 -17.5%
13.52
US$2,181,521 		161,336 -17.5% 13.52 US$2,181,521
2021-11-22 2021-11-22 S Sale
3.3
TANG KEVIN C
Large shareholder
38,664 -4.0%
6.55
US$253,373 		38,664 -4.0% 6.55 US$253,373
2021-11-22 2021-11-22 S Sale
3.3
TANG KEVIN C
Large shareholder
3,719 -0.4%
6.66
US$24,779 		3,719 -0.4% 6.66 US$24,779
2021-11-22 2021-11-22 S Sale
3.3
TANG KEVIN C
Large shareholder
196,281 -16.9%
7.11
US$1,395,185 		196,281 -16.9% 7.11 US$1,395,185
2021-11-22 2021-11-22 S Sale
3.3
TANG KEVIN C
Large shareholder
16,667 -1.4%
7.36
US$122,651 		16,667 -1.4% 7.36 US$122,651
2021-11-22 2021-11-19 S Sale
3.3
TANG KEVIN C
Large shareholder
183,333 -13.5%
7.52
US$1,378,756 		183,333 -13.5% 7.52 US$1,378,756
2021-11-22 2021-11-19 S Sale
3.3
TANG KEVIN C
Large shareholder
30,467 -2.2%
8.01
US$244,111 		30,467 -2.2% 8.01 US$244,111
2021-11-22 2021-11-18 S Sale
3.3
TANG KEVIN C
Large shareholder
169,533 -10.9%
8.09
US$1,372,319 		169,533 -10.9% 8.09 US$1,372,319
2021-11-22 2021-11-18 S Sale
3.3
TANG KEVIN C
Large shareholder
4,023 -0.3%
8.00
US$32,190 		4,023 -0.3% 8.00 US$32,190
2021-11-22 2021-11-18 S Sale
3.3
TANG KEVIN C
Large shareholder
152,764 -8.9%
8.32
US$1,271,516 		152,764 -8.9% 8.32 US$1,271,516
2021-11-22 2021-11-18 S Sale
3.3
TANG KEVIN C
Large shareholder
43,213 -2.5%
9.38
US$405,532 		43,213 -2.5% 9.38 US$405,532
2020-11-06 2020-11-06 B Purchase
3.3
TANG KEVIN C
Large shareholder
2,650 +0.2%
23.87
US$63,256 		2,650 +0.2% 23.87 US$63,256
2020-11-06 2020-11-06 B Purchase
3.3
TANG KEVIN C
Large shareholder
107,901 +6.5%
23.48
US$2,533,515 		107,901 +6.5% 23.48 US$2,533,515
2020-11-06 2020-11-06 B Purchase
3.3
TANG KEVIN C
Large shareholder
29,682 +1.8%
22.33
US$662,799 		29,682 +1.8% 22.33 US$662,799
2020-11-06 2020-11-06 B Purchase
3.3
TANG KEVIN C
Large shareholder
34,044 +2.1%
20.63
US$702,328 		34,044 +2.1% 20.63 US$702,328
2020-11-06 2020-11-05 B Purchase
3.3
TANG KEVIN C
Large shareholder
8,482 +0.5%
20.94
US$177,613 		8,482 +0.5% 20.94 US$177,613
2020-11-06 2020-11-05 B Purchase
3.3
TANG KEVIN C
Large shareholder
137,241 +9.5%
20.78
US$2,851,868 		137,241 +9.5% 20.78 US$2,851,868
2020-11-06 2020-11-05 B Purchase
3.3
TANG KEVIN C
Large shareholder
171,626 +13.5%
23.79
US$4,082,983 		171,626 +13.5% 23.79 US$4,082,983
2020-11-06 2020-11-05 B Purchase
3.3
TANG KEVIN C
Large shareholder
71,241 +6.0%
15.32
US$1,091,412 		71,241 +6.0% 15.32 US$1,091,412
2020-11-06 2020-11-05 B Purchase
3.3
TANG KEVIN C
Large shareholder
77,133 +6.9%
14.22
US$1,096,831 		77,133 +6.9% 14.22 US$1,096,831
2020-11-06 2020-11-05 B Purchase
3.3
TANG KEVIN C
Large shareholder
160,000 +16.7%
15.31
US$2,449,600 		160,000 +16.7% 15.31 US$2,449,600
2020-11-06 2020-11-04 B Purchase
3.3
TANG KEVIN C
Large shareholder
160,000 +20.0%
16.84
US$2,694,400 		160,000 +20.0% 16.84 US$2,694,400
2020-11-06 2020-11-04 B Purchase
3.3
TANG KEVIN C
Large shareholder
60,146 +8.1%
16.33
US$982,184 		60,146 +8.1% 16.33 US$982,184
2020-11-06 2020-11-04 B Purchase
3.3
TANG KEVIN C
Large shareholder
99,854 +15.6%
13.65
US$1,363,007 		99,854 +15.6% 13.65 US$1,363,007
2020-11-06 2020-11-04 B Purchase
3.3
TANG KEVIN C
Large shareholder
160,000 +33.3%
13.83
US$2,212,800 		160,000 +33.3% 13.83 US$2,212,800
2020-11-06 2020-11-04 B Purchase
3.3
TANG KEVIN C
Large shareholder
88,379 +22.6%
13.11
US$1,158,649 		88,379 +22.6% 13.11 US$1,158,649
2020-11-06 2020-11-04 B Purchase
3.3
TANG KEVIN C
Large shareholder
68,296 +21.1%
10.63
US$725,986 		68,296 +21.1% 10.63 US$725,986
2019-08-19 2019-08-16 B Purchase Maddux Randy Joe

SVP Operations, CMO

Officer
25,000 +50.0%
0.76
US$19,000 		25,000 +50.0% 0.76 US$19,000
2019-08-13 2019-08-12 PP Planned purchase El-Hibri Fuad Non-Executive Director
100,000 +9.8%
0.76
US$75,520 		100,000 +9.8% 0.76 US$75,520
2019-07-30 2019-07-29 B Purchase
2.0
El-Hibri Fuad

Board of Directors
55,015 +5.7%
0.83
US$45,861 		55,015 +5.7% 0.83 US$45,861
2019-07-24 2019-07-23 B Purchase
2.0
El-Hibri Fuad

Board of Directors
10,000 +1.0%
0.90
US$8,996 		10,000 +1.0% 0.90 US$8,996
2019-07-23 2019-07-22 B Purchase
2.0
El-Hibri Fuad

Board of Directors
30,000 +3.2%
0.89
US$26,601 		30,000 +3.2% 0.89 US$26,601
2019-07-19 2019-07-19 B Purchase
2.0
El-Hibri Fuad

Board of Directors
26,460 +2.9%
0.90
US$23,740 		26,460 +2.9% 0.90 US$23,740
2019-07-18 2019-07-18 B Purchase
2.0
El-Hibri Fuad

Board of Directors
14,404 +1.6%
0.87
US$12,596 		14,404 +1.6% 0.87 US$12,596
2019-07-18 2019-07-17 B Purchase
2.0
El-Hibri Fuad

Board of Directors
19,136 +2.2%
0.87
US$16,704 		19,136 +2.2% 0.87 US$16,704
2019-07-16 2019-07-16 B Purchase
2.0
El-Hibri Fuad

Board of Directors
11,375 +1.3%
0.85
US$9,662 		11,375 +1.3% 0.85 US$9,662
2019-07-12 2019-07-11 B Purchase
2.0
El-Hibri Fuad

Board of Directors
14,691 +1.7%
0.85
US$12,454 		14,691 +1.7% 0.85 US$12,454
2019-07-11 2019-07-10 B Purchase
2.0
El-Hibri Fuad
18,919 +2.3%
0.85
US$16,058 		18,919 +2.3% 0.85 US$16,058
2019-06-25 2019-06-25 B Purchase
0.8
Abdun-Nabi Daniel

Board of Directors
16,667 +18.0%
0.90
US$15,000 		16,667 +18.0% 0.90 US$15,000
2022-06-03 2019-06-14 B Purchase
0.7
Niederhuber John
Non-Executive Director
714 +89.0%
0.91
US$650 		714 +89.0% 0.91 US$650
2019-06-14 2019-06-14 B Purchase
2.7
White Marvin L

President and CEO
50,000 +20.5%
0.88
US$44,000 		50,000 +20.5% 0.88 US$44,000
2019-06-11 2019-06-10 B Purchase
0.8
Kunz Barbara Lopez

Board of Directors
10,000 +inf%
0.85
US$8,481 		10,000 +inf% 0.85 US$8,481
2019-06-07 2019-06-07 B Purchase
3.1
Harsanyi Zsolt

Board of Directors
50,000 +inf%
0.78
US$39,000 		50,000 +inf% 0.78 US$39,000
2019-06-07 2019-05-31 B Purchase
3.4
Maddux Randy Joe

Senior VP, Operations
20,000 +66.7%
0.73
US$14,600 		20,000 +66.7% 0.73 US$14,600
2019-05-21 2019-05-21 B Purchase
1.4
Grant Grady III

Board of Directors
10,000 +inf%
0.80
US$7,970 		10,000 +inf% 0.80 US$7,970
2019-05-20 2019-05-20 B Purchase
2.7
White Marvin L

President and CEO
30,000 +14.0%
0.81
US$24,300 		30,000 +14.0% 0.81 US$24,300
2019-05-14 2019-05-14 B Purchase
2.7
White Marvin L

President and CEO

Executive Director
10,000 +4.9%
0.78
US$7,800 		10,000 +4.9% 0.78 US$7,800
2018-12-07 2018-12-06 B Purchase Maddux Randy Joe

SVP Operations

Officer
5,000 +20.0%
2.37
US$11,850 		5,000 +20.0% 2.37 US$11,850
2018-12-06 2018-12-04 B Purchase White Marvin L

President and CEO

Executive Director
10,000 +5.2%
2.38
US$23,800 		10,000 +5.2% 2.38 US$23,800
2017-12-08 2017-11-15 B Purchase Maddux Randy Joe

Senior VP, Operations
25,000 +inf%
2.76
US$69,000 		25,000 +inf% 2.76 US$69,000
Explore more

More insider trading research around Aptevo Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America